Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tiragolumab(MTIG-7192A) is a monoclonal antibody that targets T-cell immunoglobulin and the ITIM structural domain (TIGIT).Tiragolumab is often used in combination with the PD-L1 inhibitor, Atezolizumab, for the treatment of solid malignant tumors such as non-small cell lung cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $147 | In Stock | |
5 mg | $446 | In Stock | |
10 mg | $718 | In Stock | |
25 mg | $1,090 | In Stock | |
50 mg | $1,470 | In Stock | |
100 mg | $1,980 | In Stock |
Description | Tiragolumab(MTIG-7192A) is a monoclonal antibody that targets T-cell immunoglobulin and the ITIM structural domain (TIGIT).Tiragolumab is often used in combination with the PD-L1 inhibitor, Atezolizumab, for the treatment of solid malignant tumors such as non-small cell lung cancer. |
Alias | RO 7092284, RG6058-11, RG6058-10, RG-6058, MTIG-7192A |
Molecular Weight | 148.3 kDa |
Cas No. | 1918185-84-8 |
Relative Density. | no data available |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.